Thirona, which specializes in artificial intelligence-assisted medical imaging, is spinning out its retina division, according to a press release.
The decision comes on the heels of the recent expansion of the company’s flagship software, RetCAD, which analyzes color fundus imaging for the presence of age-related macular degeneration, diabetic retinopathy and glaucoma.
Thirona Retina BV will focus on the eye diseases market and act as a stand-alone entity, the release said.
Mark van Grinsven, managing director of Thirona Retina BV, said the move will allow the retina team to concentrate on